Evonik: „Bad Bank“? Insider werfen RAG-Stiftung riskante Investments vor
Mitten im Übernahmepoker um Evonik rücken frühere Anlageentscheidungen des Großaktionärs in den Fokus – und damit die Frage, wie die Stiftung mit ihren Milliarden umgeht.
Düsseldorf: Insider have raised concerns over the investment practices of the RAG Foundation, the largest financial institution in Germany. The foundation, which owns a 44% stake in Evonik, recently handed over a majority stake in two managers of a corporate credit company it established. This move has sparked new criticism of the foundation's investment approach, which is now under intense scrutiny.
According to insiders, the foundation's investment strategy is both risky and opaque. The foundation previously came under fire from two state auditors in the spring, but these new allegations suggest that the issue runs deeper. Sources within the financial sector have provided the Handelsblatt with information about several investment decisions made by the foundation.
These allegations detail several instances from the foundation's portfolio of investments, all of which originate from internal sources within the institution itself. The foundation has not yet addressed these claims, but the timing of these revelations could not be more significant. With the European chemicals giant BASF actively pursuing a takeover of the Essen-based Evonik, the stakes have never been higher.
Written by urgent.news from Handelsblatt's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
